| Literature DB >> 35368521 |
Melanie R Wittwer1,2, Thomas Armstrong1, Jordan Conway1, Mohammed Ishaq Ruknuddeen1,2, Chris Zeitz1,3, John F Beltrame1,3, Margaret A Arstall1,2.
Abstract
Introduction: Factors associated with in-hospital mortality after out-of-hospital cardiac arrest (OHCA), such as mode of death and withdrawal of life-sustaining treatment (WLST), are not well established. This study aimed to compare clinical characteristics, timing of WLST and death, and precipitating aetiology between modes of death for OHCAs treated at hospital within a local health network.Entities:
Keywords: Aetiology; Brain death; Cause of death; DNR, Do not resuscitate; ICU, Intensive care unit; Mode of death; NALHN, Northern Adelaide Local Health Network; OHCA, Out-of-hospital cardiac arrest; Out of hospital cardiac arrest; ROSC, Return of spontaneous circulation; SAAS, SA Ambulance Service; TTM, Targeted temperature management; WLST; WLST, Withdrawal of life sustaining treatment.
Year: 2022 PMID: 35368521 PMCID: PMC8971337 DOI: 10.1016/j.resplu.2022.100229
Source DB: PubMed Journal: Resusc Plus ISSN: 2666-5204
Fig. 1Flow-chart of included patients with early death in the emergency department and late death after admission.
Patient characteristics of resuscitated OHCAs with early death in the emergency department within a local health network, stratified by mode of death.
| Overall | Cardiovascular instability | WLST | |||
|---|---|---|---|---|---|
| Male | 37 (54%) | 31 (60%) | 6 (35%) | 0.099 | |
| Age | 72 [58–84] | 70 [53–80] | 79 [68–86] | 0.023 | |
| Arrest at home or residence | 36 (52%) | 25 (48%) | 11 (65%) | 0.27 | |
| Witnessed status | |||||
| Bystander | 18 (26%) | 14 (27%) | 4 (24%) | >0.99 | |
| Emergency medical services | 34 (49%) | 29 (56%) | 5 (29%) | 0.093 | |
| Unwitnessed | 17 (25%) | 9 (17%) | 8 (47%) | 0.022 | |
| Bystander CPR | 22/34 (65%) | 14/22 (63%) | 8/12 (67%) | >0.99* | |
| Initial shockable rhythm | 13 (19%) | 11 (21%) | 2 (12%) | 0.50 | |
| Sustained ROSC ≥ 20mins | 27 (39%) | 10 (19%) | 17 (100%) | <0.001 | |
| Arrest to death (h) | 1.5 [0.9–2.3] ( | 1.2 [0.8–1.9] ( | 2.4 [1.7–4.2] | <0.001* | |
| Aetiology | <0.01 | ||||
| Cardiac | 57 (39%) | 16 (64%) | 6 (29%) | ||
| Respiratory | 42 (29%) | 3 (12%) | 9 (43%) | ||
| Neurological | 8 (5%) | 1 (4%) | 0 (0%) | ||
| Toxicological | 7 (5%) | 0 (0%) | 3 (14%) | ||
| Other | 15 (10%) | 5 (20%) | 2 (10%) | ||
| Unknown | 18 (12%) | 0 (0%) | 1 (5%) | ||
| Organ donation | 2 (3%) | 1 (2%) | 1 (6%) | – | |
Data presented as number (percentage), or median [interquartile range]. *P-values reflect data that excludes missing values. ROSC, return of spontaneous circulation; WLST, withdrawal of life-sustaining therapy.
Patient characteristics of OHCAs admitted to hospital within a local health network, stratified by mode of death.
| Overall | Cardiovascular instability | Non-neurological WLST | Neurological WLST | Brain death | |||
|---|---|---|---|---|---|---|---|
| Male | 96 (67%) | 14 (70%) | 13 (62%) | 45 (66%) | 24 (69%) | 0.96 | |
| Age | 61 [47–73] | 67 [48–78] | 70 [53–75] | 65 [52–76] | 47 [33–60] | <0.001 | |
| Arrest at home or residence | 115 (80%) | 16 (80%) | 19 (90%) | 51 (75%) | 29 (83%) | 0.47 | |
| Witnessed | 0.76 | ||||||
| Bystander | 72 (50%) | 10 (50%) | 11 (52%) | 35 (51%) | 16 (46%) | ||
| Emergency medical services | 14 (10%) | 1 (5%) | 4 (19%) | 6 (9%) | 3 (9%) | ||
| Unwitnessed | 58 (40%) | 9 (45%) | 6 (29%) | 27 (40%) | 16 (46%) | ||
| Bystander CPR | 81/130 (62%) | 15/19 (79%) | 12/17 (71%) | 33/62 (53%) | 21/32 (66%) | 0.18 | |
| Initial shockable rhythm | 51 (35%) | 11 (55%) | 7 (33%) | 26 (38%) | 7 (20%) | 0.06 | |
| Cardiac catheterisation | 55 (38%) | 10 (50%) | 7 (33%) | 26 (38%) | 12 (34%) | 0.67 | |
| Cardiac intervention | 19/55 (35%) | 6/10 (60%) | 3/7 (43%) | 7/26 (27%) | 3/12 (25%) | 0.27 | |
| Temperature management | 80 (37%) | 6 (30%) | 6 (29%) | 50 (74%) | 15 (43%) | <0.001 | |
| Neurological prognostication | |||||||
| Brain Computed Tomography | 71 (49%) | 8 (40%) | 6 (29%) | 37 (54%) | 20 (57%) | 0.12 | |
| Brain MRI | 23 (16%) | 1 (5%) | 1 (5%) | 18 (26%) | 3 (9%) | 0.016 | |
| Brain perfusion scan | 10 (7%) | - | - | - | 10 (29%) | - | |
| WLST <72 h after ROSC | 46/86 (53%) | - | 15/20 (75%) | 31/66 (47%) | - | 0.04* | |
| ROSC to WLST (h) | 70 [33–99] ( | - | 30 [12–67] ( | 74 [46–102] (n = 66) | - | <0.01* | |
| Death in Intensive Care Unit | 125 (87%) | 18 (90%) | 18 (86%) | 54 (79%) | 35 (100%) | 0.012 | |
| Arrest to death (h) | 57 [30–103] ( | 15 [8–45] | 36 [14–84] ( | 85 [48–143] ( | 48 [36–66] | <0.001 | |
| Organ donation | 23 (16%) | 1 (5%) | 1 (5%) | 6 (9%) | 15 (43%) | <0.001 | |
Data presented as number (percentage), or median [interquartile range]. *P-values reflect data that excludes missing values. MRI, magnetic resonance imaging; ROSC, return of spontaneous circulation; WLST, withdrawal of life-sustaining therapy.
Fig. 2Survival percentage according to time from arrest (h) for OHCAs with sustained ROSC admitted to hospital within a local health network, stratified by mode of death (n = 144). WLST, withdrawal of life-sustaining therapy.
Sex differences in mode of death, timing of WLST, and location and timing of death in OHCAs with sustained ROSC admitted to hospital within a local health network (n = 147).
| Missing data | Male | Female | |||
|---|---|---|---|---|---|
| WLST | 58 (59%) | 31 (63%) | 0.72 | ||
| WLST <72 h after ROSC | 3 (3%) | 29 (51%) | 17 (59%) | 0.65 | |
| ROSC to WLST (h) | 2 (2%) | 71 [33–101] | 67 [37–96] | 0.63 | |
| Death in Intensive Care Unit | - | 86 (88%) | 41 (84%) | 0.61 | |
| Arrest to death (h) | 3 (2%) | 55 [30–103] | 62 [36–110] | 0.48 | |
Data presented as number (percentage) or median [interquartile range]. p-values reflect data that excludes missing values. ROSC, return of spontaneous circulation; WLST, withdrawal of life-sustaining therapy.
Fig. 3Mode of death in OHCAs deceased after admission to hospital within a local health network, stratified according to underlying aetiology as documented in hospital medical records and autopsy reports (n = 144). WLST, withdrawal of life-sustaining therapy.